Search
for
Sort by
Research 151–180 of 1000+
- Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia
- 503 Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
- Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia, comparative study.
- Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss
- 33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism
- 33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism
- 33244 Increased risk of hyperkalemia in older women taking spironolactone for female pattern hair loss
- 451 Spironolactone for treatment of concomitant female pattern hair loss in scarring alopecia patients
- Topical Finasteride versus Topical Spironolactone in the Treatment of Androgenetic Alopecia
- A randomised trial of 5% minoxidil versus combination of 5% minoxidil and oral spironolactone in treatment of female pattern hair loss
- Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function
- Finasteride/spironolactone
- The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial
- 15809 Spironolactone use does not increase the risk of estrogen-dependent cancer recurrence: A retrospective analysis
- Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial
- Therapeutic Evaluation of Spironolactone and Finasteride in the Treatment of Acne Vulgaris
- Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
- Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent females / supplemental files
- Hair Sciences: Comments on the use of spironolactone in female pattern hair loss
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- Simultaneous Versus Delayed Initiation of Spironolactone and Low‐Dose Oral Minoxidil: Adverse Event Rates in a Retrospective Cohort Study
- Evaluation of the efficacy of topical spironolactone 5% solution versus minoxidil 5% solution vs combination of topical spironolactone 5% and minoxidil 5% solutions in female pattern hair loss
- ISID0503 – Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
- Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats
- Comparative study between topical minoxidil 5% and oral spironolactone versus topical minoxidil 5% and oral dutasteride in the treatment of women with androgenic alopecia
- Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- A Review of the Efficacy and Safety Profile of Oral Spironolactone Use for Androgenic Alopecia -Supplemental Text